{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:37:06Z","timestamp":1790012226696,"version":"4.0.1"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1038\/s41581-021-00447-x","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T17:04:14Z","timestamp":1625159054000},"page":"765-781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Aquaporin 2 regulation: implications for water balance and polycystic kidney diseases"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8835-9760","authenticated-orcid":false,"given":"Emma T. B.","family":"Olesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-199X","authenticated-orcid":false,"given":"Robert A.","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"447_CR1","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00360-018-1164-3","volume":"188","author":"CM Nawata","year":"2018","unstructured":"Nawata, C. M. & Pannabecker, T. L. Mammalian urine concentration: a review of renal medullary architecture and membrane transporters. J. Comp. Physiol. B 188, 899\u2013918 (2018).","journal-title":"J. Comp. Physiol. B"},{"key":"447_CR2","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.bbamem.2006.04.002","volume":"1758","author":"E Sohara","year":"2006","unstructured":"Sohara, E., Rai, T., Sasaki, S. & Uchida, S. Physiological roles of AQP7 in the kidney: lessons from AQP7 knockout mice. Biochim. Biophys. Acta 1758, 1106\u20131110 (2006).","journal-title":"Biochim. Biophys. Acta"},{"key":"447_CR3","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1152\/physrev.00053.2006","volume":"87","author":"RA Fenton","year":"2007","unstructured":"Fenton, R. A. & Knepper, M. A. Mouse models and the urinary concentrating mechanism in the new millennium. Physiol. Rev. 87, 1083\u20131112 (2007).","journal-title":"Physiol. Rev."},{"key":"447_CR4","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.bbagen.2013.12.002","volume":"1840","author":"ML Kortenoeven","year":"2014","unstructured":"Kortenoeven, M. L. & Fenton, R. A. Renal aquaporins and water balance disorders. Biochim. Biophys. Acta 1840, 1533\u20131549 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"447_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-pharmtox-010919-023654","volume":"60","author":"PW Cheung","year":"2020","unstructured":"Cheung, P. W., Bouley, R. & Brown, D. Targeting the\u00a0trafficking of kidney water channels for therapeutic benefit. Annu. Rev. Pharmacol. Toxicol. 60, 175\u2013194 (2020).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"447_CR6","doi-asserted-by":"publisher","first-page":"101449","DOI":"10.1016\/j.beem.2020.101449","volume":"34","author":"JG Verbalis","year":"2020","unstructured":"Verbalis, J. G. Acquired forms of central diabetes insipidus: Mechanisms of disease. Best Pract. Res. Clin. Endocrinol. Metab. 34, 101449 (2020).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"447_CR7","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres, V. E. et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 367, 2407\u20132418 (2012).","journal-title":"N. Engl. J. Med."},{"key":"447_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/ndt\/gfx043","volume":"33","author":"VE Torres","year":"2018","unstructured":"Torres, V. E. et al. Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial. Nephrol. Dial. Transpl. 33, 477\u2013489 (2018).","journal-title":"Nephrol. Dial. Transpl."},{"key":"447_CR9","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","volume":"377","author":"VE Torres","year":"2017","unstructured":"Torres, V. E. et al. Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N. Engl. J. Med. 377, 1930\u20131942 (2017).","journal-title":"N. Engl. J. Med."},{"key":"447_CR10","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/1961109a0","volume":"196","author":"H Valtin","year":"1962","unstructured":"Valtin, H., Schroeder, H. A., Benirschke, K. & Sokol, H. W. Familial hypothalamic diabetes insipidus in rats. Nature 196, 1109\u20131110 (1962).","journal-title":"Nature"},{"key":"447_CR11","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1172\/JCI39680","volume":"119","author":"JH Li","year":"2009","unstructured":"Li, J. H. et al. A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus. J. Clin. Invest. 119, 3115\u20133126 (2009).","journal-title":"J. Clin. Invest."},{"key":"447_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajpath.2012.09.014","volume":"182","author":"T Rieg","year":"2013","unstructured":"Rieg, T. et al. Adenylyl cyclase 6 enhances NKCC2 expression and mediates vasopressin-induced phosphorylation of NKCC2 and NCC. Am. J. Pathol. 182, 96\u2013106 (2013).","journal-title":"Am. J. Pathol."},{"key":"447_CR13","doi-asserted-by":"publisher","first-page":"F411","DOI":"10.1152\/ajprenal.00126.2016","volume":"311","author":"K Mutig","year":"2016","unstructured":"Mutig, K. et al. Demonstration of the functional impact of vasopressin signaling in the thick ascending limb by a targeted transgenic rat approach. Am. J. Physiol. Renal Physiol. 311, F411\u2013F423 (2016).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ki.2010.130","volume":"78","author":"NB Pedersen","year":"2010","unstructured":"Pedersen, N. B., Hofmeister, M. V., Rosenbaek, L. L., Nielsen, J. & Fenton, R. A. Vasopressin induces phosphorylation of the thiazide-sensitive sodium chloride cotransporter in the distal convoluted tubule. Kidney Int. 78, 160\u2013169 (2010).","journal-title":"Kidney Int."},{"key":"447_CR15","doi-asserted-by":"publisher","first-page":"F1166","DOI":"10.1152\/ajprenal.00196.2007","volume":"293","author":"K Mutig","year":"2007","unstructured":"Mutig, K. et al. Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL. Am. J. Physiol. Renal Physiol. 293, F1166\u2013F1177 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR16","doi-asserted-by":"publisher","first-page":"F789","DOI":"10.1152\/ajprenal.90227.2008","volume":"295","author":"P Welker","year":"2008","unstructured":"Welker, P. et al. Renal Na+-K+-Cl\u2212 cotransporter activity and vasopressin-induced trafficking are lipid raft-dependent. Am. J. Physiol. Renal Physiol. 295, F789\u2013F802 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1291\/hypres.28.671","volume":"28","author":"Y Sakuma","year":"2005","unstructured":"Sakuma, Y. et al. Differential effects of hyperosmolality on Na-K-ATPase and vasopressin-dependent cAMP generation in the medullary thick ascending limb and outer medullary collecting duct. Hypertens. Res. 28, 671\u2013679 (2005).","journal-title":"Hypertens. Res."},{"key":"447_CR18","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1681\/ASN.2010040409","volume":"21","author":"T Rieg","year":"2010","unstructured":"Rieg, T. et al. Adenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla. J. Am. Soc. Nephrol. 21, 2059\u20132068 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"447_CR19","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1172\/JCI113534","volume":"81","author":"RA Star","year":"1988","unstructured":"Star, R. A., Nonoguchi, H., Balaban, R. & Knepper, M. A. Calcium and cyclic adenosine monophosphate as second messengers for vasopressin in the rat inner medullary collecting duct. J. Clin. Invest. 81, 1879\u20131888 (1988).","journal-title":"J. Clin. Invest."},{"key":"447_CR20","first-page":"F400","volume":"275","author":"D Marples","year":"1998","unstructured":"Marples, D., Christensen, B. M., Frokiaer, J., Knepper, M. A. & Nielsen, S. Dehydration reverses vasopressin antagonist-induced diuresis and aquaporin-2 downregulation in rats. Am. J. Physiol. 275, F400\u2013F409 (1998).","journal-title":"Am. J. Physiol."},{"key":"447_CR21","doi-asserted-by":"publisher","first-page":"F193","DOI":"10.1152\/ajprenal.00304.2019","volume":"318","author":"W Su","year":"2019","unstructured":"Su, W., Cao, R., Zhang, X. Y. & Guan, Y. Aquaporins in the kidney: physiology and pathophysiology. Am. J. Physiol. Renal. Physiol. 318, F193\u2013F203 (2019).","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"447_CR22","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/ijms17071105","volume":"17","author":"XY Zhang","year":"2016","unstructured":"Zhang, X. Y., Wang, B. & Guan, Y. F. Nuclear receptor regulation of aquaporin-2 in the kidney. Int. J. Mol. Sci. 17, 1105 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"447_CR23","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1681\/ASN.2018030271","volume":"29","author":"S Li","year":"2018","unstructured":"Li, S. et al. Bile acid G protein-coupled membrane receptor TGR5 modulates aquaporin 2-mediated water homeostasis. J. Am. Soc. Nephrol. 29, 2658\u20132670 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"447_CR24","doi-asserted-by":"publisher","first-page":"F1255","DOI":"10.1152\/ajprenal.00469.2010","volume":"300","author":"C Li","year":"2011","unstructured":"Li, C. et al. Molecular mechanisms of angiotensin II stimulation on aquaporin-2 expression and trafficking. Am. J. Physiol. Renal Physiol. 300, F1255\u2013F1261 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1681\/ASN.2009121267","volume":"22","author":"R Bouley","year":"2011","unstructured":"Bouley, R. et al. Calcitonin has a vasopressin-like effect on aquaporin-2 trafficking and urinary concentration. J. Am. Soc. Nephrol. 22, 59\u201372 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"447_CR26","doi-asserted-by":"publisher","first-page":"F54","DOI":"10.1152\/ajprenal.90367.2008","volume":"296","author":"Y Yano","year":"2009","unstructured":"Yano, Y. et al. Aquaporin 2 expression increased by glucagon in normal rat inner medullary collecting ducts. Am. J. Physiol. Renal Physiol. 296, F54\u2013F59 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR27","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1128\/MCB.01088-06","volume":"27","author":"JY Chu","year":"2007","unstructured":"Chu, J. Y. et al. Phenotypes developed in secretin receptor-null mice indicated a role for secretin in regulating renal water reabsorption. Mol. Cell Biol. 27, 2499\u20132511 (2007).","journal-title":"Mol. Cell Biol."},{"key":"447_CR28","doi-asserted-by":"publisher","first-page":"F340","DOI":"10.1152\/ajprenal.00090.2006","volume":"292","author":"YJ Lee","year":"2007","unstructured":"Lee, Y. J. et al. Increased AQP2 targeting in primary cultured IMCD cells in response to angiotensin II through AT1 receptor. Am. J. Physiol. Renal Physiol. 292, F340\u2013F350 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR29","doi-asserted-by":"publisher","first-page":"12949","DOI":"10.1073\/pnas.1104691108","volume":"108","author":"ET Olesen","year":"2011","unstructured":"Olesen, E. T., Rutzler, M. R., Moeller, H. B., Praetorius, H. A. & Fenton, R. A. Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus. Proc. Natl Acad. Sci. USA 108, 12949\u201312954 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"447_CR30","doi-asserted-by":"publisher","first-page":"F1318","DOI":"10.1152\/ajprenal.00485.2016","volume":"311","author":"HJ Jung","year":"2016","unstructured":"Jung, H. J. & Kwon, T. H. Molecular mechanisms regulating aquaporin-2 in kidney collecting duct. Am. J. Physiol. Renal Physiol. 311, F1318\u2013F1328 (2016).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR31","doi-asserted-by":"publisher","first-page":"F998","DOI":"10.1152\/ajprenal.00257.2001","volume":"282","author":"TX Sun","year":"2002","unstructured":"Sun, T. X. et al. Aquaporin-2 localization in clathrin-coated pits: inhibition of endocytosis by dominant-negative dynamin. Am. J. Physiol. Renal Physiol. 282, F998\u2013F1011 (2002).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ki.2008.505","volume":"75","author":"HB Moeller","year":"2009","unstructured":"Moeller, H. B., Knepper, M. A. & Fenton, R. A. Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells. Kidney Int. 75, 295\u2013303 (2009).","journal-title":"Kidney Int."},{"key":"447_CR33","doi-asserted-by":"publisher","first-page":"F956","DOI":"10.1152\/ajprenal.00297.2019","volume":"318","author":"WL Wang","year":"2020","unstructured":"Wang, W. L. et al. Rab7 involves Vps35 to mediate AQP2 sorting and apical trafficking in collecting duct cells. Am. J. Physiol. Renal Physiol. 318, F956\u2013F970 (2020).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR34","doi-asserted-by":"publisher","first-page":"C1129","DOI":"10.1152\/ajpcell.00628.2006","volume":"293","author":"A Vossenkamper","year":"2007","unstructured":"Vossenkamper, A. et al. Microtubules are needed for the perinuclear positioning of aquaporin-2 after its endocytic retrieval in renal principal cells. Am. J. Physiol. Cell Physiol. 293, C1129\u2013C1138 (2007).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"447_CR35","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1210\/en.2004-0073","volume":"145","author":"Y Tajika","year":"2004","unstructured":"Tajika, Y. et al. Aquaporin-2 is retrieved to the apical storage compartment via early endosomes and phosphatidylinositol 3-kinase-dependent pathway. Endocrinology 145, 4375\u20134383 (2004).","journal-title":"Endocrinology"},{"key":"447_CR36","doi-asserted-by":"publisher","first-page":"F1294","DOI":"10.1152\/ajprenal.00307.2016","volume":"311","author":"MS Lee","year":"2016","unstructured":"Lee, M. S., Choi, H. J., Park, E. J., Park, H. J. & Kwon, T. H. Depletion of vacuolar protein sorting-associated protein 35 is associated with increased lysosomal degradation of aquaporin-2. Am. J. Physiol. Renal Physiol. 311, F1294\u2013F1307 (2016).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1600-0854.2006.00508.x","volume":"8","author":"PI Nedvetsky","year":"2007","unstructured":"Nedvetsky, P. I. et al. A role of myosin Vb and Rab11-FIP2 in the aquaporin-2 shuttle. Traffic 8, 110\u2013123 (2007).","journal-title":"Traffic"},{"key":"447_CR38","doi-asserted-by":"publisher","first-page":"C38","DOI":"10.1152\/ajpcell.00109.2012","volume":"304","author":"N Yui","year":"2013","unstructured":"Yui, N. et al. Basolateral targeting and microtubule-dependent transcytosis of the aquaporin-2 water channel. Am. J. Physiol. Cell Physiol. 304, C38\u2013C48 (2013).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"447_CR39","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/cells9041057","volume":"9","author":"R Bouley","year":"2020","unstructured":"Bouley, R., Yui, N., Terlouw, A., Cheung, P. W. & Brown, D. Chlorpromazine induces basolateral aquaporin-2 accumulation via F-actin depolymerization and blockade of endocytosis in renal epithelial cells. Cells 9, 1057 (2020).","journal-title":"Cells"},{"key":"447_CR40","doi-asserted-by":"publisher","first-page":"F789","DOI":"10.1152\/ajprenal.00281.2019","volume":"317","author":"V Deshpande","year":"2019","unstructured":"Deshpande, V. et al. Phosphoproteomic identification of vasopressin V2 receptor-dependent signaling in the renal collecting duct. Am. J. Physiol. Renal Physiol. 317, F789\u2013F804 (2019).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR41","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1073\/pnas.0600895103","volume":"103","author":"JD Hoffert","year":"2006","unstructured":"Hoffert, J. D., Pisitkun, T., Wang, G., Shen, R. F. & Knepper, M. A. Quantitative phosphoproteomics of vasopressin-sensitive renal cells: regulation of aquaporin-2 phosphorylation at two sites. Proc. Natl Acad. Sci. USA 103, 7159\u20137164 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"447_CR42","doi-asserted-by":"publisher","first-page":"24617","DOI":"10.1074\/jbc.M803074200","volume":"283","author":"JD Hoffert","year":"2008","unstructured":"Hoffert, J. D. et al. Vasopressin-stimulated increase in phosphorylation at Ser269 potentiates plasma membrane retention of aquaporin-2. J. Biol. Chem. 283, 24617\u201324627 (2008).","journal-title":"J. Biol. Chem."},{"key":"447_CR43","doi-asserted-by":"publisher","first-page":"F1018","DOI":"10.1152\/ajprenal.00580.2009","volume":"298","author":"L Xie","year":"2010","unstructured":"Xie, L. et al. Quantitative analysis of aquaporin-2 phosphorylation. Am. J. Physiol. Renal Physiol. 298, F1018\u2013F1023 (2010).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR44","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1073\/pnas.0910683107","volume":"107","author":"HB Moeller","year":"2010","unstructured":"Moeller, H. B., Praetorius, J., Rutzler, M. R. & Fenton, R. A. Phosphorylation of aquaporin-2 regulates its endocytosis and protein-protein interactions. Proc. Natl Acad. Sci. USA 107, 424\u2013429 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"447_CR45","doi-asserted-by":"publisher","first-page":"7984","DOI":"10.1074\/jbc.M117.779611","volume":"292","author":"PJ Wang","year":"2017","unstructured":"Wang, P. J. et al. Vasopressin-induced serine 269 phosphorylation reduces Sipa1l1 (signal-induced proliferation-associated 1 like 1)-mediated aquaporin-2 endocytosis. J. Biol. Chem. 292, 7984\u20137993 (2017).","journal-title":"J. Biol. Chem."},{"key":"447_CR46","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.3390\/ijms20215351","volume":"20","author":"JV Roche","year":"2019","unstructured":"Roche, J. V., Nesverova, V., Olsson, C., Deen, P. M. & Tornroth-Horsefield, S. Structural insights into AQP2 targeting to multivesicular bodies. Int. J. Mol. Sci. 20, 5351 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"447_CR47","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.3390\/ijms18112255","volume":"18","author":"JV Roche","year":"2017","unstructured":"Roche, J. V. & Tornroth-Horsefield, S. Aquaporin protein-protein interactions. Int. J. Mol. Sci. 18, 2255 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"447_CR48","doi-asserted-by":"publisher","first-page":"14636","DOI":"10.1074\/jbc.M117.788364","volume":"292","author":"JV Roche","year":"2017","unstructured":"Roche, J. V. et al. Phosphorylation of human aquaporin 2 (AQP2) allosterically controls its interaction with the lysosomal trafficking protein LIP5. J. Biol. Chem. 292, 14636\u201314648 (2017).","journal-title":"J. Biol. Chem."},{"key":"447_CR49","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3390\/cells9051208","volume":"9","author":"HJ Choi","year":"2020","unstructured":"Choi, H. J. et al. Sorting nexin 27 regulates the lysosomal degradation of aquaporin-2 protein in the kidney collecting duct. Cells 9, 1208 (2020).","journal-title":"Cells"},{"key":"447_CR50","doi-asserted-by":"publisher","first-page":"18344","DOI":"10.1073\/pnas.0604073103","volume":"103","author":"EJ Kamsteeg","year":"2006","unstructured":"Kamsteeg, E. J. et al. Short-chain ubiquitination mediates the regulated endocytosis of the aquaporin-2 water channel. Proc. Natl Acad. Sci. USA 103, 18344\u201318349 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"447_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183774","volume":"12","author":"C Trimpert","year":"2017","unstructured":"Trimpert, C. et al. NDFIP allows NEDD4\/NEDD4L-induced AQP2 ubiquitination and degradation. PLoS ONE 12, e0183774 (2017).","journal-title":"PLoS ONE"},{"key":"447_CR52","doi-asserted-by":"publisher","first-page":"F883","DOI":"10.1152\/ajprenal.00117.2011","volume":"301","author":"YJ Lee","year":"2011","unstructured":"Lee, Y. J. et al. E3 ubiquitin-protein ligases in rat kidney collecting duct: response to vasopressin stimulation and withdrawal. Am. J. Physiol. Renal Physiol. 301, F883\u2013F896 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR53","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1152\/physiolgenomics.00031.2016","volume":"48","author":"B Medvar","year":"2016","unstructured":"Medvar, B., Raghuram, V., Pisitkun, T., Sarkar, A. & Knepper, M. A. Comprehensive database of human E3 ubiquitin ligases: application to aquaporin-2 regulation. Physiol. Genomics 48, 502\u2013512 (2016).","journal-title":"Physiol. Genomics"},{"key":"447_CR54","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1681\/ASN.2017050526","volume":"29","author":"Q Wu","year":"2018","unstructured":"Wu, Q. et al. CHIP regulates aquaporin-2 quality control and body water homeostasis. J. Am. Soc. Nephrol. 29, 936\u2013948 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"447_CR55","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1159\/000485088","volume":"44","author":"M Centrone","year":"2017","unstructured":"Centrone, M. et al. AQP2 abundance is regulated by the E3-ligase CHIP Via HSP70. Cell Physiol. Biochem. 44, 515\u2013531 (2017).","journal-title":"Cell Physiol. Biochem."},{"key":"447_CR56","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/cells9030673","volume":"9","author":"A Dema","year":"2020","unstructured":"Dema, A. et al. Cyclin-dependent kinase 18 controls trafficking of aquaporin-2 and its abundance through ubiquitin ligase STUB1, which functions as an AKAP. Cells 9, 673 (2020).","journal-title":"Cells"},{"key":"447_CR57","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/cells8030265","volume":"8","author":"SK Murali","year":"2019","unstructured":"Murali, S. K., Aroankins, T. S., Moeller, H. B. & Fenton, R. A. The deubiquitylase USP4 interacts with the water channel AQP2 to modulate its apical membrane accumulation and cellular abundance. Cells 8, 265 (2019).","journal-title":"Cells"},{"key":"447_CR58","first-page":"3174","volume":"127","author":"HB Moeller","year":"2014","unstructured":"Moeller, H. B., Aroankins, T. S., Slengerik-Hansen, J., Pisitkun, T. & Fenton, R. A. Phosphorylation and ubiquitylation are opposing processes that regulate endocytosis of the water channel aquaporin-2. J. Cell Sci. 127, 3174\u20133183 (2014).","journal-title":"J. Cell Sci."},{"key":"447_CR59","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1074\/jbc.M115.691121","volume":"291","author":"HB Moeller","year":"2016","unstructured":"Moeller, H. B. et al. Regulation of the water channel aquaporin-2 via 14-3-3theta and -zeta. J. Biol. Chem. 291, 2469\u20132484 (2016).","journal-title":"J. Biol. Chem."},{"key":"447_CR60","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1681\/ASN.2018060668","volume":"30","author":"T Vukicevic","year":"2019","unstructured":"Vukicevic, T. et al. Fluconazole increases osmotic water transport in renal collecting duct through effects on aquaporin-2 trafficking. J. Am. Soc. Nephrol. 30, 795\u2013810 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"447_CR61","doi-asserted-by":"publisher","first-page":"17119","DOI":"10.1073\/pnas.1309219110","volume":"110","author":"CS Loo","year":"2013","unstructured":"Loo, C. S. et al. Quantitative apical membrane proteomics reveals vasopressin-induced actin dynamics in collecting duct cells. Proc. Natl Acad. Sci. USA 110, 17119\u201317124 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"447_CR62","doi-asserted-by":"publisher","first-page":"C757","DOI":"10.1152\/ajpcell.1993.265.3.C757","volume":"265","author":"H Simon","year":"1993","unstructured":"Simon, H., Gao, Y., Franki, N. & Hays, R. M. Vasopressin depolymerizes apical F-actin in rat inner medullary collecting duct. Am. J. Physiol. 265, C757\u2013C762 (1993).","journal-title":"Am. J. Physiol."},{"key":"447_CR63","doi-asserted-by":"publisher","first-page":"49026","DOI":"10.1074\/jbc.M408565200","volume":"279","author":"CL Chou","year":"2004","unstructured":"Chou, C. L. et al. Non-muscle myosin II and myosin light chain kinase are downstream targets for vasopressin signaling in the renal collecting duct. J. Biol. Chem. 279, 49026\u201349035 (2004).","journal-title":"J. Biol. Chem."},{"key":"447_CR64","doi-asserted-by":"publisher","first-page":"20451","DOI":"10.1074\/jbc.M010270200","volume":"276","author":"E Klussmann","year":"2001","unstructured":"Klussmann, E. et al. An inhibitory role of Rho in the vasopressin-mediated translocation of aquaporin-2 into cell membranes of renal principal cells. J. Biol. Chem. 276, 20451\u201320457 (2001).","journal-title":"J. Biol. Chem."},{"key":"447_CR65","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3390\/cells9061354","volume":"9","author":"M Ranieri","year":"2020","unstructured":"Ranieri, M. et al. The vasopressin receptor 2 mutant R137L linked to the nephrogenic syndrome of inappropriate antidiuresis (NSIAD) signals through an alternative pathway that increases AQP2 membrane targeting independently of S256 phosphorylation. Cells 9, 1354 (2020).","journal-title":"Cells"},{"key":"447_CR66","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1056\/NEJMoa042743","volume":"352","author":"BJ Feldman","year":"2005","unstructured":"Feldman, B. J. et al. Nephrogenic syndrome of inappropriate antidiuresis. N. Engl. J. Med. 352, 1884\u20131890 (2005).","journal-title":"N. Engl. J. Med."},{"key":"447_CR67","doi-asserted-by":"publisher","first-page":"F306","DOI":"10.1152\/ajprenal.00391.2017","volume":"314","author":"L Lei","year":"2018","unstructured":"Lei, L. et al. Manganese promotes intracellular accumulation of AQP2 via modulating F-actin polymerization and reduces urinary concentration in mice. Am. J. Physiol. Renal Physiol. 314, F306\u2013F316 (2018).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR68","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1242\/jcs.205922","volume":"130","author":"W Li","year":"2017","unstructured":"Li, W. et al. Ezrin directly interacts with AQP2 and promotes its endocytosis. J. Cell Sci. 130, 2914\u20132925 (2017).","journal-title":"J. Cell Sci."},{"key":"447_CR69","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ceb.2011.04.011","volume":"23","author":"AL Neisch","year":"2011","unstructured":"Neisch, A. L. & Fehon, R. G. Ezrin, radixin and moesin: key regulators of membrane-cortex interactions and signaling. Curr. Opin. Cell Biol. 23, 377\u2013382 (2011).","journal-title":"Curr. Opin. Cell Biol."},{"key":"447_CR70","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/emboj\/16.1.35","volume":"16","author":"DT Dransfield","year":"1997","unstructured":"Dransfield, D. T. et al. Ezrin is a cyclic AMP-dependent protein kinase anchoring protein. EMBO J. 16, 35\u201343 (1997).","journal-title":"EMBO J."},{"key":"447_CR71","first-page":"391","volume":"14","author":"LL Brunton","year":"1981","unstructured":"Brunton, L. L., Hayes, J. S. & Mayer, S. E. Functional compartmentation of cyclic AMP and protein kinase in heart. Adv. Cyclic Nucleotide Res. 14, 391\u2013397 (1981).","journal-title":"Adv. Cyclic Nucleotide Res."},{"key":"447_CR72","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1056\/NEJMc1505505","volume":"373","author":"MA Knepper","year":"2015","unstructured":"Knepper, M. A., Kwon, T. H. & Nielsen, S. Molecular physiology of water balance. N. Engl. J. Med. 373, 196 (2015).","journal-title":"N. Engl. J. Med."},{"key":"447_CR73","unstructured":"Nedvetsky, P. I. et al. in Aquaporins. Handbook of Experimental Pharmacology Vol. 190 (ed. Beitz, E.) (Springer, 2009)."},{"key":"447_CR74","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1042\/BC20040120","volume":"97","author":"Y Noda","year":"2005","unstructured":"Noda, Y. & Sasaki, S. Trafficking mechanism of water channel aquaporin-2. Biol. Cell 97, 885\u2013892 (2005).","journal-title":"Biol. Cell"},{"key":"447_CR75","first-page":"F817","volume":"272","author":"T Katsura","year":"1997","unstructured":"Katsura, T., Gustafson, C. E., Ausiello, D. A. & Brown, D. Protein kinase A phosphorylation is involved in regulated exocytosis of aquaporin-2 in transfected LLC-PK1 cells. Am. J. Physiol. 272, F817\u2013F822 (1997).","journal-title":"Am. J. Physiol."},{"key":"447_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39116-2","volume":"9","author":"K Limbutara","year":"2019","unstructured":"Limbutara, K., Kelleher, A., Yang, C. R., Raghuram, V. & Knepper, M. A. Phosphorylation changes in response to kinase inhibitor H89 in PKA-null cells. Sci. Rep. 9, 2814 (2019).","journal-title":"Sci. Rep."},{"key":"447_CR77","doi-asserted-by":"publisher","first-page":"F627","DOI":"10.1152\/ajprenal.00222.2014","volume":"308","author":"ML Gilbert","year":"2015","unstructured":"Gilbert, M. L., Yang, L., Su, T. & McKnight, G. S. Expression of a dominant negative PKA mutation in the kidney elicits a diabetes insipidus phenotype. Am. J. Physiol. Renal Physiol. 308, F627\u2013F638 (2015).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR78","doi-asserted-by":"publisher","first-page":"E8875","DOI":"10.1073\/pnas.1709123114","volume":"114","author":"K Isobe","year":"2017","unstructured":"Isobe, K. et al. Systems-level identification of PKA-dependent signaling in epithelial cells. Proc. Natl Acad. Sci. USA 114, E8875\u2013E8884 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"447_CR79","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1096\/fj.201902982R","volume":"34","author":"A Datta","year":"2020","unstructured":"Datta, A. et al. PKA-independent vasopressin signaling in renal collecting duct. FASEB J. 34, 6129\u20136146 (2020).","journal-title":"FASEB J."},{"key":"447_CR80","doi-asserted-by":"publisher","first-page":"C123","DOI":"10.1152\/ajpcell.00377.2012","volume":"307","author":"D Bradford","year":"2014","unstructured":"Bradford, D. et al. Use of LC-MS\/MS and Bayes\u2019 theorem to identify protein kinases that phosphorylate aquaporin-2 at Ser256. Am. J. Physiol. Cell Physiol. 307, C123\u2013C139 (2014).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"447_CR81","doi-asserted-by":"publisher","first-page":"F253","DOI":"10.1152\/ajprenal.00491.2017","volume":"316","author":"JK Liwang","year":"2019","unstructured":"Liwang, J. K. et al. Role of PKC and AMPK in hypertonicity-stimulated water reabsorption in rat inner medullary collecting ducts. Am. J. Physiol. Renal Physiol. 316, F253\u2013F262 (2019).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR82","doi-asserted-by":"publisher","first-page":"F890","DOI":"10.1152\/ajprenal.00308.2016","volume":"311","author":"MM Al-Bataineh","year":"2016","unstructured":"Al-Bataineh, M. M. et al. Activation of the metabolic sensor AMP-activated protein kinase inhibits aquaporin-2 function in kidney principal cells. Am. J. Physiol. Renal Physiol. 311, F890\u2013F900 (2016).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR83","doi-asserted-by":"publisher","first-page":"F1008","DOI":"10.1152\/ajprenal.00102.2016","volume":"310","author":"JD Klein","year":"2016","unstructured":"Klein, J. D. et al. Metformin, an AMPK activator, stimulates the phosphorylation of aquaporin 2 and urea transporter A1 in inner medullary collecting ducts. Am. J. Physiol. Renal Physiol. 310, F1008\u2013F1012 (2016).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR84","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.88409","volume":"1","author":"O Efe","year":"2016","unstructured":"Efe, O., Klein, J. D., LaRocque, L. M., Ren, H. & Sands, J. M. Metformin improves urine concentration in rodents with nephrogenic diabetes insipidus. JCI Insight 1, e88409 (2016).","journal-title":"JCI Insight"},{"key":"447_CR85","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13665","volume":"6","author":"AP Bech","year":"2018","unstructured":"Bech, A. P., Wetzels, J. F. M. & Nijenhuis, T. Effects of sildenafil, metformin, and simvastatin on ADH-independent urine concentration in healthy volunteers. Physiol. Rep. 6, e13665 (2018).","journal-title":"Physiol. Rep."},{"key":"447_CR86","doi-asserted-by":"publisher","first-page":"F744","DOI":"10.1152\/ajprenal.00010.2017","volume":"312","author":"ET Olesen","year":"2017","unstructured":"Olesen, E. T. & Fenton, R. A. Aquaporin-2 membrane targeting: still a conundrum. Am. J. Physiol. Renal Physiol. 312, F744\u2013F747 (2017).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR87","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.cell.2020.07.043","volume":"182","author":"JZ Zhang","year":"2020","unstructured":"Zhang, J. Z. et al. Phase separation of a PKA regulatory subunit controls cAMP compartmentation and oncogenic signaling. Cell 182, 1531\u20131544.e15 (2020).","journal-title":"Cell"},{"key":"447_CR88","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.cell.2020.07.035","volume":"182","author":"A Bock","year":"2020","unstructured":"Bock, A. et al. Optical mapping of cAMP signaling at the nanometer scale. Cell 182, 1519\u20131530.e17 (2020).","journal-title":"Cell"},{"key":"447_CR89","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1681\/ASN.2006020132","volume":"18","author":"E Stefan","year":"2007","unstructured":"Stefan, E. et al. Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells. J. Am. Soc. Nephrol. 18, 199\u2013212 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"447_CR90","doi-asserted-by":"publisher","first-page":"6578","DOI":"10.1073\/pnas.1117862109","volume":"109","author":"S Liu","year":"2012","unstructured":"Liu, S. et al. Phosphodiesterases coordinate cAMP propagation induced by two stimulatory G protein-coupled receptors in hearts. Proc. Natl Acad. Sci. USA 109, 6578\u20136583 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"447_CR91","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.tips.2020.09.007","volume":"41","author":"MH Omar","year":"2020","unstructured":"Omar, M. H. & Scott, J. D. AKAP signaling islands: venues for precision pharmacology. Trends Pharmacol. Sci. 41, 933\u2013946 (2020).","journal-title":"Trends Pharmacol. Sci."},{"key":"447_CR92","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.tcb.2020.06.002","volume":"30","author":"LM Wingler","year":"2020","unstructured":"Wingler, L. M. & Lefkowitz, R. J. Conformational basis of G protein-coupled receptor signaling versatility. Trends Cell Biol. 30, 736\u2013747 (2020).","journal-title":"Trends Cell Biol."},{"key":"447_CR93","doi-asserted-by":"publisher","first-page":"F935","DOI":"10.1152\/ajprenal.00559.2015","volume":"311","author":"ET Olesen","year":"2016","unstructured":"Olesen, E. T., Moeller, H. B., Assentoft, M., MacAulay, N. & Fenton, R. A. The vasopressin type 2 receptor and prostaglandin receptors EP2 and EP4 can increase aquaporin-2 plasma membrane targeting through a cAMP-independent pathway. Am. J. Physiol. Renal Physiol. 311, F935\u2013F944 (2016).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR94","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/280078a0","volume":"280","author":"LL Brunton","year":"1979","unstructured":"Brunton, L. L., Hayes, J. S. & Mayer, S. E. Hormonally specific phosphorylation of cardiac troponin I and activation of glycogen phosphorylase. Nature 280, 78\u201380 (1979).","journal-title":"Nature"},{"key":"447_CR95","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1016\/S0021-9258(19)70757-1","volume":"255","author":"JS Hayes","year":"1980","unstructured":"Hayes, J. S., Brunton, L. L. & Mayer, S. E. Selective activation of particulate cAMP-dependent protein kinase by isoproterenol and prostaglandin E1. J. Biol. Chem. 255, 5113\u20135119 (1980).","journal-title":"J. Biol. Chem."},{"key":"447_CR96","doi-asserted-by":"publisher","first-page":"26654","DOI":"10.1074\/jbc.M312835200","volume":"279","author":"V Henn","year":"2004","unstructured":"Henn, V. et al. Identification of a novel A-kinase anchoring protein 18 isoform and evidence for its role in the vasopressin-induced aquaporin-2 shuttle in renal principal cells. J. Biol. Chem. 279, 26654\u201326665 (2004).","journal-title":"J. Biol. Chem."},{"key":"447_CR97","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.1074\/jbc.274.8.4934","volume":"274","author":"E Klussmann","year":"1999","unstructured":"Klussmann, E., Maric, K., Wiesner, B., Beyermann, M. & Rosenthal, W. Protein kinase A anchoring proteins are required for vasopressin-mediated translocation of aquaporin-2 into cell membranes of renal principal cells. J. Biol. Chem. 274, 4934\u20134938 (1999).","journal-title":"J. Biol. Chem."},{"key":"447_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03771-2","volume":"9","author":"F Ando","year":"2018","unstructured":"Ando, F. et al. AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus. Nat. Commun. 9, 1411 (2018).","journal-title":"Nat. Commun."},{"key":"447_CR99","doi-asserted-by":"publisher","first-page":"9079","DOI":"10.1074\/jbc.M110.160614","volume":"286","author":"F Christian","year":"2011","unstructured":"Christian, F. et al. Small molecule AKAP-protein kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes. J. Biol. Chem. 286, 9079\u20139096 (2011).","journal-title":"J. Biol. Chem."},{"key":"447_CR100","doi-asserted-by":"publisher","first-page":"23285","DOI":"10.1074\/jbc.M110.124545","volume":"285","author":"MW Friedrich","year":"2010","unstructured":"Friedrich, M. W., Aramuni, G., Mank, M., Mackinnon, J. A. & Griesbeck, O. Imaging CREB activation in living cells. J. Biol. Chem. 285, 23285\u201323295 (2010).","journal-title":"J. Biol. Chem."},{"key":"447_CR101","first-page":"755","volume":"16","author":"Y Wang","year":"2006","unstructured":"Wang, Y., Chen, Y., Chen, M. & Xu, W. AKAPs competing peptide HT31 disrupts the inhibitory effect of PKA on RhoA activity. Oncol. Rep. 16, 755\u2013761 (2006).","journal-title":"Oncol. Rep."},{"key":"447_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191423","volume":"13","author":"K Schrade","year":"2018","unstructured":"Schrade, K. et al. An AKAP-Lbc-RhoA interaction inhibitor promotes the translocation of aquaporin-2 to the plasma membrane of renal collecting duct principal cells. PLoS ONE 13, e0191423 (2018).","journal-title":"PLoS ONE"},{"key":"447_CR103","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1113\/JP277024","volume":"597","author":"PW Cheung","year":"2019","unstructured":"Cheung, P. W., Terlouw, A., Janssen, S. A., Brown, D. & Bouley, R. Inhibition of non-receptor tyrosine kinase Src induces phosphoserine 256-independent aquaporin-2 membrane accumulation. J. Physiol. 597, 1627\u20131642 (2019).","journal-title":"J. Physiol."},{"key":"447_CR104","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1177\/1078155215592023","volume":"22","author":"J Hill","year":"2016","unstructured":"Hill, J., Shields, J. & Passero, V. Tyrosine kinase inhibitor-associated syndrome of inappropriate secretion of anti-diuretic hormone. J. Oncol. Pharm. Pract. 22, 729\u2013732 (2016).","journal-title":"J. Oncol. Pharm. Pract."},{"key":"447_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13636","volume":"7","author":"F Ando","year":"2016","unstructured":"Ando, F. et al. Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway. Nat. Commun. 7, 13636 (2016).","journal-title":"Nat. Commun."},{"key":"447_CR106","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1681\/ASN.2012030295","volume":"24","author":"J Bogum","year":"2013","unstructured":"Bogum, J. et al. Small-molecule screening identifies modulators of aquaporin-2 trafficking. J. Am. Soc. Nephrol. 24, 744\u2013758 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"447_CR107","doi-asserted-by":"publisher","first-page":"F746","DOI":"10.1152\/ajprenal.00339.2020","volume":"319","author":"LA Mortensen","year":"2020","unstructured":"Mortensen, L. A., Bistrup, C., Jensen, B. L. & Hinrichs, G. R. A mini-review of pharmacological strategies used to ameliorate polyuria associated with X-linked nephrogenic diabetes insipidus. Am. J. Physiol. Renal Physiol. 319, F746\u2013F753 (2020).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR108","doi-asserted-by":"publisher","first-page":"C597","DOI":"10.1152\/ajpcell.00154.2014","volume":"307","author":"N Nomura","year":"2014","unstructured":"Nomura, N. et al. High-throughput chemical screening identifies AG-490 as a stimulator of aquaporin 2 membrane expression and urine concentration. Am. J. Physiol. Cell Physiol. 307, C597\u2013C605 (2014).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"447_CR109","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1113\/jphysiol.1994.sp020168","volume":"477","author":"CB Gow","year":"1994","unstructured":"Gow, C. B. & Phillips, P. A. Epidermal growth factor as a diuretic in sheep. J. Physiol. 477, 27\u201333 (1994).","journal-title":"J. Physiol."},{"key":"447_CR110","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1681\/ASN.2015080903","volume":"27","author":"PW Cheung","year":"2016","unstructured":"Cheung, P. W. et al. EGF receptor inhibition by erlotinib increases aquaporin 2-mediated renal water reabsorption. J. Am. Soc. Nephrol. 27, 3105\u20133116 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"447_CR111","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1056\/NEJM199307293290508","volume":"329","author":"PA Gabow","year":"1993","unstructured":"Gabow, P. A. Autosomal dominant polycystic kidney disease. N. Engl. J. Med. 329, 332\u2013342 (1993).","journal-title":"N. Engl. J. Med."},{"key":"447_CR112","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4103\/1319-2442.252908","volume":"30","author":"M Hajji","year":"2019","unstructured":"Hajji, M. et al. Clinical study on autosomal dominant polycystic kidney disease among North Tunisians. Saudi J. Kidney Dis. Transpl. 30, 175\u2013184 (2019).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"447_CR113","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1681\/ASN.2018060590","volume":"29","author":"FT Chebib","year":"2018","unstructured":"Chebib, F. T. et al. A practical guide for treatment of rapidly progressive ADPKD with tolvaptan. J. Am. Soc. Nephrol. 29, 2458\u20132470 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"447_CR114","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1056\/NEJMra1010172","volume":"364","author":"F Hildebrandt","year":"2011","unstructured":"Hildebrandt, F., Benzing, T. & Katsanis, N. Ciliopathies. N. Engl. J. Med. 364, 1533\u20131543 (2011).","journal-title":"N. Engl. J. Med."},{"key":"447_CR115","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41581-019-0143-6","volume":"15","author":"D Douguet","year":"2019","unstructured":"Douguet, D., Patel, A. & Honore, E. Structure and function of polycystins: insights into polycystic kidney disease. Nat. Rev. Nephrol. 15, 412\u2013422 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"447_CR116","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1152\/physrev.00014.2019","volume":"100","author":"J Leipziger","year":"2020","unstructured":"Leipziger, J. & Praetorius, H. A. Renal autocrine and paracrine signaling: a story of self-protection. Physiol. Rev. 100, 1229\u20131289 (2020).","journal-title":"Physiol. Rev."},{"key":"447_CR117","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fphys.2013.00292","volume":"4","author":"P Svenningsen","year":"2013","unstructured":"Svenningsen, P., Burford, J. L. & Peti-Peterdi, J. ATP releasing connexin 30 hemichannels mediate flow-induced calcium signaling in the collecting duct. Front. Physiol. 4, 292 (2013).","journal-title":"Front. Physiol."},{"key":"447_CR118","doi-asserted-by":"publisher","first-page":"F930","DOI":"10.1152\/ajprenal.00285.2006","volume":"292","author":"C Xu","year":"2007","unstructured":"Xu, C. et al. Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling. Am. J. Physiol. Renal Physiol. 292, F930\u2013F945 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR119","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","volume":"17","author":"S Shibazaki","year":"2008","unstructured":"Shibazaki, S. et al. Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1. Hum. Mol. Genet. 17, 1505\u20131516 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"447_CR120","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ng.2715","volume":"45","author":"M Ma","year":"2013","unstructured":"Ma, M., Tian, X., Igarashi, P., Pazour, G. J. & Somlo, S. Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease. Nat. Genet. 45, 1004\u20131012 (2013).","journal-title":"Nat. Genet."},{"key":"447_CR121","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1681\/ASN.2007070828","volume":"19","author":"B Yang","year":"2008","unstructured":"Yang, B., Sonawane, N. D., Zhao, D., Somlo, S. & Verkman, A. S. Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease. J. Am. Soc. Nephrol. 19, 1300\u20131310 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"447_CR122","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.3389\/fphys.2018.01765","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Genetic deletion of P2Y2 receptor offers long-term (5 months) protection against lithium-induced polyuria, natriuresis, kaliuresis, and collecting duct remodeling and cell proliferation. Front. Physiol. 9, 1765 (2018).","journal-title":"Front. Physiol."},{"key":"447_CR123","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1152\/physrev.1998.78.4.1165","volume":"78","author":"LP Sullivan","year":"1998","unstructured":"Sullivan, L. P., Wallace, D. P. & Grantham, J. J. Epithelial transport in polycystic kidney disease. Physiol. Rev. 78, 1165\u20131191 (1998).","journal-title":"Physiol. Rev."},{"key":"447_CR124","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41581-019-0183-y","volume":"15","author":"LF Menezes","year":"2019","unstructured":"Menezes, L. F. & Germino, G. G. The pathobiology of polycystic kidney disease from a metabolic viewpoint. Nat. Rev. Nephrol. 15, 735\u2013749 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"447_CR125","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","volume":"393","author":"E Cornec-Le Gall","year":"2019","unstructured":"Cornec-Le Gall, E., Alam, A. & Perrone, R. D. Autosomal dominant polycystic kidney disease. Lancet 393, 919\u2013935 (2019).","journal-title":"Lancet"},{"key":"447_CR126","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1101\/gad.315127.118","volume":"32","author":"J Cai","year":"2018","unstructured":"Cai, J. et al. A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease. Genes Dev. 32, 781\u2013793 (2018).","journal-title":"Genes Dev."},{"key":"447_CR127","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1681\/ASN.2009040421","volume":"21","author":"JM Shillingford","year":"2010","unstructured":"Shillingford, J. M., Piontek, K. B., Germino, G. G. & Weimbs, T. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. J. Am. Soc. Nephrol. 21, 489\u2013497 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"447_CR128","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1073\/pnas.0509694103","volume":"103","author":"JM Shillingford","year":"2006","unstructured":"Shillingford, J. M. et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc. Natl Acad. Sci. USA 103, 5466\u20135471 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"447_CR129","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.135385","volume":"5","author":"AJ Streets","year":"2020","unstructured":"Streets, A. J., Prosseda, P. P. & Ong, A. C. Polycystin-1 regulates ARHGAP35-dependent centrosomal RhoA activation and ROCK signaling. JCI Insight 5, e135385 (2020).","journal-title":"JCI Insight"},{"key":"447_CR130","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra, A. L. et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 820\u2013829 (2010).","journal-title":"N. Engl. J. Med."},{"key":"447_CR131","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G Walz","year":"2010","unstructured":"Walz, G. et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 830\u2013840 (2010).","journal-title":"N. Engl. J. Med."},{"key":"447_CR132","doi-asserted-by":"publisher","first-page":"17090","DOI":"10.1074\/jbc.RA119.010320","volume":"294","author":"MK Yanda","year":"2019","unstructured":"Yanda, M. K., Cha, B., Cebotaru, C. V. & Cebotaru, L. Pharmacological reversal of renal cysts from secretion to absorption suggests a potential therapeutic strategy for managing autosomal dominant polycystic kidney disease. J. Biol. Chem. 294, 17090\u201317104 (2019).","journal-title":"J. Biol. Chem."},{"key":"447_CR133","doi-asserted-by":"publisher","first-page":"11513","DOI":"10.1074\/jbc.RA118.001846","volume":"293","author":"MK Yanda","year":"2018","unstructured":"Yanda, M. K., Liu, Q. & Cebotaru, L. A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector. J. Biol. Chem. 293, 11513\u201311526 (2018).","journal-title":"J. Biol. Chem."},{"key":"447_CR134","doi-asserted-by":"publisher","first-page":"F917","DOI":"10.1152\/ajprenal.00616.2011","volume":"302","author":"CC Graffe","year":"2012","unstructured":"Graffe, C. C., Bech, J. N., Lauridsen, T. G. & Pedersen, E. B. Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion. Am. J. Physiol. Renal Physiol. 302, F917\u2013F927 (2012).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR135","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1681\/ASN.2012010079","volume":"23","author":"Y Chen","year":"2012","unstructured":"Chen, Y. et al. Aquaporin 2 promotes cell migration and epithelial morphogenesis. J. Am. Soc. Nephrol. 23, 1506\u20131517 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"447_CR136","doi-asserted-by":"publisher","first-page":"F537","DOI":"10.1152\/ajprenal.00622.2017","volume":"315","author":"EHJ Verschuren","year":"2018","unstructured":"Verschuren, E. H. J. et al. Polycystin-1 dysfunction impairs electrolyte and water handling in a renal precystic mouse model for ADPKD. Am. J. Physiol. Renal Physiol. 315, F537\u2013F546 (2018).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR137","doi-asserted-by":"publisher","first-page":"F1005","DOI":"10.1152\/ajprenal.00243.2011","volume":"301","author":"GA Reif","year":"2011","unstructured":"Reif, G. A. et al. Tolvaptan inhibits ERK-dependent cell proliferation, Cl\u2212 secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin. Am. J. Physiol. Renal Physiol. 301, F1005\u2013F1013 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR138","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.kint.2017.08.005","volume":"93","author":"Q Wang","year":"2018","unstructured":"Wang, Q. et al. Adenylyl cyclase 5 deficiency reduces renal cyclic AMP and cyst growth in an orthologous mouse model of polycystic kidney disease. Kidney Int. 93, 403\u2013415 (2018).","journal-title":"Kidney Int."},{"key":"447_CR139","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1681\/ASN.2013010077","volume":"25","author":"S Rees","year":"2014","unstructured":"Rees, S. et al. Adenylyl cyclase 6 deficiency ameliorates polycystic kidney disease. J. Am. Soc. Nephrol. 25, 232\u2013237 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"447_CR140","doi-asserted-by":"publisher","first-page":"F1412","DOI":"10.1152\/ajprenal.00692.2011","volume":"303","author":"CS Pinto","year":"2012","unstructured":"Pinto, C. S., Reif, G. A., Nivens, E., White, C. & Wallace, D. P. Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl\u2212 secretion by human autosomal dominant polycystic kidney cells. Am. J. Physiol. Renal Physiol. 303, F1412\u2013F1424 (2012).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43002-2","volume":"9","author":"RT Sherpa","year":"2019","unstructured":"Sherpa, R. T. et al. Sensory primary cilium is a responsive cAMP microdomain in renal epithelia. Sci. Rep. 9, 6523 (2019).","journal-title":"Sci. Rep."},{"key":"447_CR142","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1681\/ASN.2016111232","volume":"28","author":"V Tesar","year":"2017","unstructured":"Tesar, V. et al. Bosutinib versus placebo for autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 28, 3404\u20133413 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"447_CR143","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2215\/CJN.08350813","volume":"9","author":"MA Cadnapaphornchai","year":"2014","unstructured":"Cadnapaphornchai, M. A. et al. Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 9, 889\u2013896 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"447_CR144","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ebiom.2019.08.041","volume":"47","author":"WN Leonhard","year":"2019","unstructured":"Leonhard, W. N. et al. Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease. EBioMedicine 47, 436\u2013445 (2019).","journal-title":"EBioMedicine"},{"key":"447_CR145","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/bph.14558","volume":"176","author":"X Lian","year":"2019","unstructured":"Lian, X. et al. The combination of metformin and 2-deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease. Br. J. Pharmacol. 176, 711\u2013724 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"447_CR146","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1073\/pnas.1011498108","volume":"108","author":"V Takiar","year":"2011","unstructured":"Takiar, V. et al. Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proc. Natl Acad. Sci. USA 108, 2462\u20132467 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"447_CR147","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12882-018-1090-3","volume":"19","author":"A Pisani","year":"2018","unstructured":"Pisani, A., Riccio, E., Bruzzese, D. & Sabbatini, M. Metformin in autosomal dominant polycystic kidney disease: experimental hypothesis or clinical fact? BMC Nephrol. 19, 282 (2018).","journal-title":"BMC Nephrol."},{"key":"447_CR148","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3389\/fonc.2015.00228","volume":"5","author":"AS Nikonova","year":"2015","unstructured":"Nikonova, A. S. et al. Opposing effects of inhibitors of aurora-A and EGFR in autosomal-dominant polycystic kidney disease. Front. Oncol. 5, 228 (2015).","journal-title":"Front. Oncol."},{"key":"447_CR149","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/LGT.0000000000000496","volume":"24","author":"LM Collins","year":"2020","unstructured":"Collins, L. M., Moore, R. & Sobel, J. D. Prognosis and long-term outcome of women with idiopathic recurrent vulvovaginal candidiasis caused by candida albicans. J. Low. Genit. Tract Dis. 24, 48\u201352 (2020).","journal-title":"J. Low. Genit. Tract Dis."},{"key":"447_CR150","doi-asserted-by":"publisher","first-page":"F677","DOI":"10.1152\/ajprenal.00119.2017","volume":"313","author":"H Ye","year":"2017","unstructured":"Ye, H. et al. The regulatory 1alpha subunit of protein kinase A modulates renal cystogenesis. Am. J. Physiol. Renal Physiol. 313, F677\u2013F686 (2017).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"447_CR151","doi-asserted-by":"publisher","first-page":"C417","DOI":"10.1152\/ajpcell.2000.278.2.C417","volume":"278","author":"P Huang","year":"2000","unstructured":"Huang, P., Trotter, K., Boucher, R. C., Milgram, S. L. & Stutts, M. J. PKA holoenzyme is functionally coupled to CFTR by AKAPs. Am. J. Physiol. Cell Physiol. 278, C417\u2013C422 (2000).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"447_CR152","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.00150.2020","volume":"319","author":"RA Fenton","year":"2020","unstructured":"Fenton, R. A., Murali, S. K. & Moeller, H. B. Advances in aquaporin-2 trafficking mechanisms and their implications for treatment of water balance disorders. Am. J. Physiol. Cell Physiol. 319, C1\u2013C10 (2020).","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00447-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T14:23:45Z","timestamp":1634221425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00447-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":152,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["447"],"URL":"https:\/\/doi.org\/10.1038\/s41581-021-00447-x","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"assertion":[{"value":"21 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}